PT3794148T - Métodos de diagnóstico de aneurisma ou cancro - Google Patents

Métodos de diagnóstico de aneurisma ou cancro

Info

Publication number
PT3794148T
PT3794148T PT187261128T PT18726112T PT3794148T PT 3794148 T PT3794148 T PT 3794148T PT 187261128 T PT187261128 T PT 187261128T PT 18726112 T PT18726112 T PT 18726112T PT 3794148 T PT3794148 T PT 3794148T
Authority
PT
Portugal
Prior art keywords
blood test
diagnostic blood
diagnostic
test
blood
Prior art date
Application number
PT187261128T
Other languages
English (en)
Original Assignee
Twobull Meditherapy P C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Twobull Meditherapy P C filed Critical Twobull Meditherapy P C
Publication of PT3794148T publication Critical patent/PT3794148T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT187261128T 2018-05-17 2018-05-17 Métodos de diagnóstico de aneurisma ou cancro PT3794148T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2018/062897 WO2019219195A1 (en) 2018-05-17 2018-05-17 Diagnostic blood test

Publications (1)

Publication Number Publication Date
PT3794148T true PT3794148T (pt) 2022-09-27

Family

ID=62217965

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187261128T PT3794148T (pt) 2018-05-17 2018-05-17 Métodos de diagnóstico de aneurisma ou cancro

Country Status (15)

Country Link
EP (1) EP3794148B1 (pt)
JP (2) JP7437768B2 (pt)
KR (1) KR20210028149A (pt)
CN (1) CN112534066A (pt)
AU (1) AU2018423766A1 (pt)
CA (1) CA3100100A1 (pt)
DK (1) DK3794148T3 (pt)
ES (1) ES2931273T3 (pt)
HU (1) HUE059900T2 (pt)
LT (1) LT3794148T (pt)
MX (1) MX2020012161A (pt)
PT (1) PT3794148T (pt)
RS (1) RS63600B1 (pt)
SI (1) SI3794148T1 (pt)
WO (1) WO2019219195A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230092930A (ko) * 2020-10-30 2023-06-26 에프. 호프만-라 로슈 아게 담관암종의 표지자로서의 timp1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004289953B2 (en) 2003-06-18 2008-09-25 Genelux Corporation Modified recombinant vaccina viruses and other microorganisms, uses thereof
CA2532722C (en) * 2003-07-17 2016-10-04 Pacific Edge Biotechnology, Ltd. Cystatin sn (cst1) and other markers for detection of gastric cancer
ES2324435B1 (es) * 2005-10-27 2010-05-31 Fundacion Para El Estudio De La Hematologia Y Hemoterapia De Aragon (Fehha) Procedimiento y dispositivo de analisis in vitro de mrna de genes implicados en neoplasias hematologicas.
CA2804119A1 (en) * 2010-05-25 2011-12-01 National Cancer Center Induced malignant stem cells or pre-induction cancer stem cells capable of self-replication outside of an organism, production method for same, and practical application for same
US20190127805A1 (en) * 2016-03-15 2019-05-02 Almac Diagnostics Limited Gene signatures for cancer detection and treatment

Also Published As

Publication number Publication date
CN112534066A (zh) 2021-03-19
JP2021530964A (ja) 2021-11-18
HUE059900T2 (hu) 2023-01-28
RS63600B1 (sr) 2022-10-31
LT3794148T (lt) 2022-10-10
CA3100100A1 (en) 2019-11-21
JP2024012341A (ja) 2024-01-30
WO2019219195A1 (en) 2019-11-21
EP3794148A1 (en) 2021-03-24
DK3794148T3 (da) 2022-09-26
ES2931273T3 (es) 2022-12-28
JP7437768B2 (ja) 2024-02-26
MX2020012161A (es) 2021-04-12
US20210102258A1 (en) 2021-04-08
EP3794148B1 (en) 2022-07-06
KR20210028149A (ko) 2021-03-11
SI3794148T1 (sl) 2022-11-30
AU2018423766A1 (en) 2020-12-24

Similar Documents

Publication Publication Date Title
CA185208S (en) Medical probe
GB201719423D0 (en) Diagnostic tests
GB201507827D0 (en) Diagnostic test
GB201608781D0 (en) Non-invasive blood analysis
CA191601S (en) Medical examination probe
EP3713489C0 (en) INTEGRATED BLOOD TESTING DEVICE
GB201816376D0 (en) Diagnostic test
GB2579122B (en) Tissue analysis
GB201700487D0 (en) Diagnostic
EP3834747C0 (en) MEDICAL INSTRUMENT
GB201904861D0 (en) Diagnosis
PT3794148T (pt) Métodos de diagnóstico de aneurisma ou cancro
IL271368A (en) Medical examination device
HUE064848T2 (hu) Diagnosztikai berendezés
GB2606734B (en) Diagnostic testing
CA190051S (en) Instrument for medical diagnosis
GB201804737D0 (en) Diagnostic procedure
EP3737948A4 (en) DIAGNOSTIC TEST
GB201719755D0 (en) Diagnostic test
GB201811451D0 (en) Blood analysis
EP3743723C0 (en) MEDICAL TEST CARD
GB202312659D0 (en) Diagnostic testing
GB202117404D0 (en) Diagnostic test
CA192957S (en) Test strip for medical or laboratory purposes
CA192958S (en) Test strip for medical or laboratory purposes